Tissue inhibitors of metalloproteases: Regulation and biological activities

被引:120
作者
Fassina, G
Ferrari, N
Brigati, C
Benelli, R
Santi, L
Noonan, DM
Albini, A
机构
[1] Ist Nazl Ric Canc, Ctr Biotecnol Avanzate, Mol Biol Lab, I-16132 Genoa, Italy
[2] CNR, Ctr Neurofisiol Cerebrale, Genoa, Italy
[3] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
[4] Ctr Biotecnol Avanzate, CBA, Genoa, Italy
关键词
basement membrane; invasion; metalloproteases; TIMPs;
D O I
10.1023/A:1006797522521
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A central role in tissue invasion is played by proteases that degrade extracellular matrices; in particular specific metalloproteases (MMPs) have been frequently correlated with the invasive potential of tumor cells and with the angiogenic process. MMPs are tightly regulated by molecules controlling their activation and by specific inhibitors of MMPs, known as the Tissue Inhibitors of MetalloProteases or TIMPs. Four TIMP family members are currently known. An imbalance between MMPs and TIMPs is linked to the degradation of the extracellular matrix associated with several physiologic and pathologic events including angiogenesis, invasion and metastasis. TIMPs are not only the `guardians' of tissue degradation, they are able to control cell proliferation and cell survival as well. Given the critical role that TIMPs play, it is vital to know how the expression of TIMPs is controlled. Here we review the major biological properties and the molecular regulation of the TIMP expression.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 96 条
[51]   Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines [J].
Kurschat, P ;
Zigrino, P ;
Nischt, R ;
Breitkopf, K ;
Steurer, P ;
Klein, CE ;
Krieg, T ;
Mauch, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21056-21062
[52]   Vascular endothelial growth factor increases release of gelatinase a and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro [J].
Lamoreaux, WJ ;
Fitzgerald, MEC ;
Reiner, A ;
Hasty, KA ;
Charles, ST .
MICROVASCULAR RESEARCH, 1998, 55 (01) :29-42
[53]  
LECO KJ, 1994, J BIOL CHEM, V269, P9352
[54]  
Lee OH, 2000, BRIT J CANCER, V82, P385
[55]  
Li GY, 1999, CANCER RES, V59, P6267
[56]   Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes [J].
Lim, MS ;
Guedez, L ;
Stetler-Stevenson, WG ;
Stetler-Stevenson, M .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :522-523
[57]   CANCER METASTASIS AND ANGIOGENESIS - AN IMBALANCE OF POSITIVE AND NEGATIVE REGULATION [J].
LIOTTA, LA ;
STEEG, PS ;
STETLERSTEVENSON, WG .
CELL, 1991, 64 (02) :327-336
[58]   Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors [J].
Logan, SK ;
Garabedian, MJ ;
Campbell, CE ;
Werb, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :774-782
[59]   Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53 [J].
Loging, WT ;
Reisman, D .
ONCOGENE, 1999, 18 (52) :7608-7615
[60]   ROLE OF PROTEIN-SYNTHESIS, PROSTAGLANDINS, AND ESTROGEN IN RAT OVARIAN METALLOPROTEINASE INHIBITOR PRODUCTION [J].
MANN, JS ;
KINDY, MS ;
HYDE, JF ;
CLARK, MR ;
CURRY, TE .
BIOLOGY OF REPRODUCTION, 1993, 48 (05) :1006-1013